6-Nitroquinazolines with dual TNF-alpha production/T-cell proliferation-suppressive effects Dec. 2, 1999
Potent, selective, orally active and nonulcerogenic COX-2 inhibitor identified at Merck Frosst Dec. 1, 1999
RSS